Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 352 | 3.150 |
Why?
|
| Mammography | 12 | 2017 | 34 | 2.310 |
Why?
|
| Kidney Failure, Chronic | 18 | 2021 | 158 | 2.070 |
Why?
|
| Racism | 4 | 2022 | 32 | 1.940 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 80 | 1.870 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 76 | 1.810 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 103 | 1.770 |
Why?
|
| Health Status Disparities | 5 | 2020 | 70 | 1.640 |
Why?
|
| Renal Replacement Therapy | 10 | 2011 | 24 | 1.610 |
Why?
|
| Registries | 16 | 2011 | 191 | 1.610 |
Why?
|
| Kidney Transplantation | 8 | 2021 | 126 | 1.450 |
Why?
|
| Medically Uninsured | 2 | 2021 | 11 | 1.280 |
Why?
|
| Physicians | 2 | 2022 | 116 | 1.160 |
Why?
|
| Humans | 76 | 2023 | 29829 | 0.990 |
Why?
|
| Primary Health Care | 3 | 2021 | 95 | 0.920 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 129 | 0.910 |
Why?
|
| Health Facilities | 1 | 2023 | 18 | 0.860 |
Why?
|
| Health Equity | 1 | 2023 | 17 | 0.840 |
Why?
|
| Chicago | 23 | 2019 | 867 | 0.840 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 142 | 0.830 |
Why?
|
| Middle Aged | 43 | 2021 | 9953 | 0.820 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.810 |
Why?
|
| Female | 56 | 2021 | 16417 | 0.810 |
Why?
|
| Referral and Consultation | 3 | 2021 | 85 | 0.780 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 156 | 0.760 |
Why?
|
| Community Health Services | 1 | 2021 | 31 | 0.760 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 37 | 0.760 |
Why?
|
| Dyslipidemias | 2 | 2018 | 23 | 0.740 |
Why?
|
| Health Personnel | 1 | 2022 | 115 | 0.740 |
Why?
|
| Renal Dialysis | 10 | 2021 | 110 | 0.740 |
Why?
|
| Socioeconomic Factors | 11 | 2020 | 329 | 0.730 |
Why?
|
| Adult | 37 | 2021 | 8731 | 0.720 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 64 | 0.710 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 221 | 0.700 |
Why?
|
| Mass Screening | 10 | 2017 | 180 | 0.690 |
Why?
|
| Hospitalization | 2 | 2022 | 319 | 0.670 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 6 | 0.670 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 4 | 0.670 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 411 | 0.660 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 33 | 0.640 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 28 | 0.620 |
Why?
|
| Violence | 1 | 2018 | 39 | 0.610 |
Why?
|
| Survival Rate | 7 | 2011 | 376 | 0.610 |
Why?
|
| Aged | 32 | 2021 | 9633 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 334 | 0.600 |
Why?
|
| Mortality | 5 | 2018 | 86 | 0.570 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 77 | 0.530 |
Why?
|
| United Kingdom | 12 | 2011 | 51 | 0.520 |
Why?
|
| Residence Characteristics | 5 | 2019 | 216 | 0.510 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 1 | 0.510 |
Why?
|
| Health Policy | 2 | 2015 | 50 | 0.500 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.500 |
Why?
|
| Insurance Coverage | 1 | 2015 | 13 | 0.500 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 16 | 0.490 |
Why?
|
| Young Adult | 13 | 2021 | 1966 | 0.460 |
Why?
|
| Male | 32 | 2021 | 15858 | 0.450 |
Why?
|
| Cause of Death | 4 | 2011 | 64 | 0.440 |
Why?
|
| Hospitals | 4 | 2022 | 157 | 0.440 |
Why?
|
| Waiting Lists | 2 | 2010 | 15 | 0.430 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 12 | 0.430 |
Why?
|
| Community Health Planning | 2 | 2009 | 21 | 0.410 |
Why?
|
| United States | 10 | 2021 | 2344 | 0.410 |
Why?
|
| Tissue Donors | 2 | 2010 | 73 | 0.410 |
Why?
|
| Peritoneal Dialysis | 2 | 2011 | 22 | 0.400 |
Why?
|
| Retrospective Studies | 12 | 2021 | 3325 | 0.390 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 970 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 696 | 0.380 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 857 | 0.370 |
Why?
|
| Hemoglobins | 4 | 2009 | 83 | 0.370 |
Why?
|
| Adolescent | 9 | 2021 | 2331 | 0.370 |
Why?
|
| National Health Programs | 2 | 2010 | 5 | 0.360 |
Why?
|
| Cesarean Section | 4 | 2014 | 30 | 0.360 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 13 | 0.360 |
Why?
|
| Risk Factors | 11 | 2018 | 2466 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2018 | 683 | 0.340 |
Why?
|
| Community Participation | 1 | 2009 | 15 | 0.340 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.320 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.320 |
Why?
|
| Medical Audit | 1 | 2008 | 7 | 0.320 |
Why?
|
| ErbB Receptors | 1 | 2009 | 73 | 0.320 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 4941 | 0.320 |
Why?
|
| Incidence | 8 | 2019 | 759 | 0.310 |
Why?
|
| Pregnancy | 8 | 2020 | 388 | 0.310 |
Why?
|
| Smoking | 2 | 2005 | 194 | 0.290 |
Why?
|
| Hospitals, Public | 6 | 2002 | 31 | 0.290 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 140 | 0.280 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.270 |
Why?
|
| Guideline Adherence | 3 | 2018 | 67 | 0.260 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.260 |
Why?
|
| Heroin Dependence | 1 | 2005 | 10 | 0.260 |
Why?
|
| Public Health | 2 | 2017 | 62 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 18 | 0.260 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.260 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 17 | 0.250 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.240 |
Why?
|
| Smoking Cessation | 1 | 2005 | 50 | 0.240 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 7 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3557 | 0.230 |
Why?
|
| Age Factors | 6 | 2018 | 852 | 0.230 |
Why?
|
| New Zealand | 6 | 2019 | 13 | 0.230 |
Why?
|
| Time Factors | 6 | 2018 | 1640 | 0.230 |
Why?
|
| Health Status Indicators | 1 | 2004 | 78 | 0.230 |
Why?
|
| Cities | 3 | 2018 | 14 | 0.220 |
Why?
|
| Asthma | 1 | 2005 | 137 | 0.220 |
Why?
|
| Poverty | 5 | 2010 | 97 | 0.220 |
Why?
|
| Commerce | 1 | 2023 | 13 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 51 | 0.210 |
Why?
|
| Patient Transfer | 2 | 1996 | 20 | 0.210 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2019 | 331 | 0.200 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 14 | 0.200 |
Why?
|
| Morbidity | 2 | 2001 | 63 | 0.200 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.200 |
Why?
|
| Public Health Administration | 1 | 2001 | 10 | 0.200 |
Why?
|
| Patient Compliance | 3 | 2018 | 165 | 0.190 |
Why?
|
| Social Class | 3 | 2010 | 65 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 23 | 0.190 |
Why?
|
| Health Surveys | 3 | 2007 | 96 | 0.180 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.180 |
Why?
|
| Research Design | 2 | 2020 | 214 | 0.180 |
Why?
|
| Income | 2 | 2005 | 77 | 0.170 |
Why?
|
| Cholesterol | 2 | 2018 | 54 | 0.170 |
Why?
|
| Neoplasms | 2 | 2017 | 257 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 79 | 0.170 |
Why?
|
| Sociology, Medical | 1 | 2019 | 2 | 0.170 |
Why?
|
| Prevalence | 6 | 2014 | 494 | 0.160 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 35 | 0.160 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.160 |
Why?
|
| Illinois | 4 | 2015 | 241 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2009 | 310 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 16 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 18 | 0.160 |
Why?
|
| Quality of Health Care | 4 | 2020 | 138 | 0.160 |
Why?
|
| Global Health | 1 | 2018 | 55 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| England | 4 | 2011 | 14 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 618 | 0.150 |
Why?
|
| Germany | 1 | 2017 | 10 | 0.150 |
Why?
|
| Medical Overuse | 1 | 2017 | 6 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 707 | 0.150 |
Why?
|
| Comorbidity | 2 | 2017 | 504 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2017 | 113 | 0.150 |
Why?
|
| Women's Health | 2 | 2017 | 247 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 14 | 0.140 |
Why?
|
| Health Education | 3 | 1994 | 41 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 364 | 0.140 |
Why?
|
| Quality Control | 1 | 2016 | 45 | 0.140 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 2 | 0.140 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 20 | 0.140 |
Why?
|
| Prognosis | 4 | 2012 | 874 | 0.140 |
Why?
|
| Urban Health | 3 | 2004 | 23 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 558 | 0.140 |
Why?
|
| Observer Variation | 1 | 2016 | 119 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 214 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 48 | 0.140 |
Why?
|
| Urban Population | 5 | 2005 | 143 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 34 | 0.130 |
Why?
|
| Wales | 3 | 2010 | 4 | 0.130 |
Why?
|
| Civil Defense | 1 | 2015 | 7 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 39 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.130 |
Why?
|
| Financing, Government | 1 | 2015 | 14 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 13 | 0.130 |
Why?
|
| Patient Safety | 1 | 2016 | 50 | 0.130 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.130 |
Why?
|
| Stereotyping | 1 | 2015 | 8 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 21 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 297 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 34 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2015 | 38 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 1953 | 0.120 |
Why?
|
| Students, Medical | 1 | 2015 | 44 | 0.120 |
Why?
|
| Syphilis | 1 | 1994 | 4 | 0.120 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 4 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 16 | 0.120 |
Why?
|
| Community Health Nursing | 1 | 1994 | 11 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 802 | 0.120 |
Why?
|
| Postpartum Period | 1 | 1993 | 24 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 87 | 0.100 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.100 |
Why?
|
| Disasters | 1 | 2011 | 4 | 0.100 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.100 |
Why?
|
| Tetanus | 1 | 2011 | 10 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 21 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 85 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 19 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1859 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 94 | 0.090 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.090 |
Why?
|
| Patient Selection | 2 | 2011 | 234 | 0.090 |
Why?
|
| Living Donors | 1 | 2009 | 7 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 34 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 42 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1821 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 286 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 47 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 410 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2002 | 130 | 0.080 |
Why?
|
| Mexico | 1 | 2007 | 17 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 532 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 66 | 0.070 |
Why?
|
| HIV Infections | 1 | 1994 | 997 | 0.070 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 24 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 3 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 2 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 542 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 13 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 927 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 225 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 654 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 24 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 10 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 98 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 297 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 158 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 89 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2005 | 312 | 0.050 |
Why?
|
| Critical Care | 1 | 2005 | 242 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 812 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1376 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 11 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 9 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 67 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 298 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1634 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 123 | 0.050 |
Why?
|
| Phosphates | 2 | 2010 | 21 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 13 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 28 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 19 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 17 | 0.040 |
Why?
|
| North America | 1 | 2018 | 39 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 1 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 14 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 95 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 22 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 20 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 118 | 0.040 |
Why?
|
| Community Health Centers | 3 | 1993 | 12 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 640 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Calcium | 2 | 2010 | 496 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 60 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 15 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 13 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 54 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 24 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 20 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 4 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 78 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 33 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 135 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 194 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 18 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 50 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 10 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 8 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 20 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 10 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 41 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 63 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 25 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 10 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 346 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 3 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 9 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 24 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 216 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 10 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 17 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 6 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 5 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 24 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 30 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 16 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 28 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2005 | 140 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1462 | 0.020 |
Why?
|
| Physical Examination | 2 | 1993 | 117 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 9 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 325 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 26 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 13 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 108 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 8 | 0.000 |
Why?
|
| Time | 1 | 1986 | 17 | 0.000 |
Why?
|